Trial intelligence / Profile preview

Calcipotriol/Betamethasone Regimens in Psoriasis

NCT00216892Phase 4Completed

Sponsor
LEO Pharma
Start
Apr 2005
Modality
Orthosteric Ligands
Countries
7
01

Overview

A Phase 4 trial of calcipotriol in Psoriasis vulgaris (PV), sponsored by LEO Pharma. Started Apr 2005; status: completed.

02

Drugs

calcipotriol
03

Conditions

Psoriasis vulgaris (PV)

Beyond the preview

Go deeper on NCT00216892.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00216892.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call